(Q48841023)

16 February 2018

title

HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape (English)

1 reference

16 February 2018

1 reference

R Bingham

1

1 reference

16 February 2018

N Ahmed

2

1 reference

16 February 2018

P Rangi

3

1 reference

16 February 2018

M Johnson

4

1 reference

16 February 2018

M Tyrer

5

1 reference

16 February 2018

J Green

6

1 reference

16 February 2018

publication date

1 October 2011

1 reference

16 February 2018

International Journal of STD & AIDS

published in

1 reference

16 February 2018

volume

22

1 reference

16 February 2018

issue

10

1 reference

16 February 2018

page(s)

608-609

1 reference

16 February 2018

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

cites work

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

Antiretroviral therapy and central nervous system HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.010507

21 January 2018

Identifiers

DOI

10.1258/IJSA.2011.010507

1 reference

16 February 2018

1 reference

16 February 2018